DESIGN OF A PHASE III, DOUBLE-BLIND, RANDOMIZED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF ALLOGENEIC STEM CELLS (DARVADSTROCEL) FOR THE TREATMENT OF COMPLEX PERIANAL FISTULA(S) IN PATIENTS WITH CROHN'S DISEASE (ADMIRE-CD II TRIAL).

被引:0
|
作者
Wexner, S.
Sandborn, W.
Panes, J.
Gilaberte, I.
Gulati, P.
Zhang, B.
Pfeifer, J.
Garcia-Olmo, D.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P1158
引用
收藏
页码:E300 / E300
页数:1
相关论文
共 50 条
  • [2] EFFICACY AND SAFETY OF DARVADSTROCEL TREATMENT IN PATIENTS WITH COMPLEX PERIANAL FISTULAS AND CROHN'S DISEASE: RESULTS FROM THE GLOBAL ADMIRE-CD II PHASE 3 STUDY
    Serclova, Zuzana
    Garcia-Olmo, Damian
    Chen, Szu-Ta
    Wexner, Steven D.
    Panes, Julian
    Wu, Chunyuan
    Fleshner, Phillip
    Zhang, Barbara
    Colombel, Jean Frederic
    Song, Michael
    McKay, Caroline
    Nazarey, Pradeep
    Wright, Ekaterina
    Raffals, Laura H.
    GASTROENTEROLOGY, 2024, 166 (05) : S181 - S181
  • [3] Efficacy and safety of darvadstrocel treatment in patients with complex perianal fistulas and Crohn's Disease: results from the global ADMIRE-CD II phase 3 study
    Serclova, Z.
    Garcia-Olmo, D.
    Chen, S. T.
    Wexner, S.
    Panes, J.
    Wu, C.
    Fleshner, P.
    Zhang, B.
    Colombel, J. F.
    Song, M.
    McKay, C.
    Nazarey, P.
    Wright, E.
    Raffals, L.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I34 - I35
  • [4] Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn's Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial
    Garcia-Olmo, Damian
    Gilaberte, Inmaculada
    Binek, Matthias
    Hoore, Andre J. L. D.
    Lindner, Dirk
    Selvaggi, Francesco
    Spinelli, Antonino
    Panes, Julian
    DISEASES OF THE COLON & RECTUM, 2022, 65 (05) : 713 - 720
  • [5] INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn's Disease Treated in the ADMIRE-CD Trial
    Panes, Julian
    Bouma, Gerd
    Ferrante, Marc
    Kucharzik, Torsten
    Nachury, Maria
    de la Portilla de Juan, Fernando
    Reinisch, Walter
    Selvaggi, Francesco
    Tschmelitsch, Jorg
    Brett, Neil R.
    Ladouceur, Martin
    Binek, Matthias
    Hantsbarger, Gary
    Campbell-Hill, Sarah
    Karki, Chitra
    Buskens, Christianne
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (11) : 1737 - 1745
  • [7] Darvadstrocel treatment outcomes in Crohn's disease patients with complex perianal fistulas: the role of TNFi co-treatment in ADMIRE CD
    Panes, J.
    Garcia-Olmo, D.
    Lindner, D.
    Garcia, I. Tagarro
    Agboton, C.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S327 - S328
  • [8] DARVADSTROCEL TREATMENT OUTCOMES IN CROHN'S DISEASE PATIENTS WITH COMPLEX PERIANAL FISTULAS: THE ROLE OF TNFI CO-TREATMENT IN ADMIRE CD
    Panes, Julian
    Garcia-Olmo, Damian
    Lindner, Dirk
    Garcia, Ignacio Tagarro
    Agboton, Christian
    GASTROENTEROLOGY, 2019, 156 (06) : S1098 - S1099
  • [9] Efficacy and Safety of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Crohn's Disease
    Chowla, Navreet M.
    Tariq, Raseen
    Aggarwal, Manik
    Loftus, Edward V.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S820 - S821
  • [10] Allogeneic adipose-derived stem cells for the treatment of perianal fistula in Crohn's disease: a pilot clinical trial
    Park, K. J.
    Ryoo, S. -B.
    Kim, J. S.
    Kim, T. I.
    Baik, S. H.
    Kim, H. J.
    Lee, K. Y.
    Kim, M.
    Kim, W. H.
    COLORECTAL DISEASE, 2016, 18 (05) : 468 - 476